APRE · Company research
Aprea Therapeutics, Inc. Common stock (APRE): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| 12 Health Care Stocks Moving In Thursday's After-Market Session - SCWorx Corp. - Common Stock (NASDAQ:WOR - Benzinga | 12 Health Care Stocks Moving In Thursday's After-Market Session - SCWorx Corp. - Common Stock (NASDAQ:WOR Benzinga | View source ↗ | Benzinga | Oct 8, 2026 | neutral | 0 | 0.6 |
| APRE: Aprea Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | APRE: Aprea Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics, Inc. (APRE) Stock Price, News, Quote & History - Yahoo! Finance Canada | Aprea Therapeutics, Inc. (APRE) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| Two consecutive conference days put Aprea's CEO in a fireside chat and panel. - Stock Titan | Two consecutive conference days put Aprea's CEO in a fireside chat and panel. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics (APRE) Ticks Higher: Shares Near $0.78 as Buyers Defend $0.74 Support - Gamma Exposure - siam.in | Aprea Therapeutics (APRE) Ticks Higher: Shares Near $0.78 as Buyers Defend $0.74 Support - Gamma Exposure siam.in | View source ↗ | siam.in | Sep 30, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics (APRE) Ticks Higher: Shares Near $0.78 as Buyers Defend $0.74 Support - MACD Signal Stocks - https://www.dars.gov.et/ | Aprea Therapeutics (APRE) Ticks Higher: Shares Near $0.78 as Buyers Defend $0.74 Support - MACD Signal Stocks https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Sep 30, 2026 | neutral | 0 | 0.6 |
| Unusual volume stocks in Wednesday's session - ChartMill | Unusual volume stocks in Wednesday's session ChartMill | View source ↗ | ChartMill | Aug 26, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics records second consecutive surge, jumping another 22% (APRE:NASDAQ) - Seeking Alpha | Aprea Therapeutics records second consecutive surge, jumping another 22% (APRE:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 25, 2026 | neutral | 0 | 0.6 |
| Aprea (APRE) Technical Snapshot: Slides 2.03% to $0.68 for the Current Session; Session Range View: Price Remains Between $0.65 Support and $0.71 Resistance under the Current Snapshot - Gap Up Stocks - dars.gov.et | Aprea (APRE) Technical Snapshot: Slides 2.03% to $0.68 for the Current Session; Session Range View: Price Remains Between $0.65 Support and $0.71 Resistance under the Current Snapshot - Gap Up Stocks dars.gov.et | View source ↗ | dars.gov.et | Aug 18, 2026 | neutral | 0 | 0.6 |
| APRE Forecast — Price Target — Prediction for 2027 - TradingView | APRE Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| APRE: All agenda items, including director elections and reverse stock split, were approved - TradingView | APRE: All agenda items, including director elections and reverse stock split, were approved TradingView | View source ↗ | TradingView | Jun 16, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics (NASDAQ:APRE) Q1 2026 Results: Clinical Progress Drives Stock Higher - ChartMill | Aprea Therapeutics (NASDAQ:APRE) Q1 2026 Results: Clinical Progress Drives Stock Higher ChartMill | View source ↗ | ChartMill | May 13, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics Stock Rises After Company Reports Second Unconfirmed Case Of Tumor Reduction In Trial - Stocktwits | Aprea Therapeutics Stock Rises After Company Reports Second Unconfirmed Case Of Tumor Reduction In Trial Stocktwits | View source ↗ | Stocktwits | Mar 5, 2026 | neutral | 0 | 0.6 |
| Aprea Therapeutics (APRE) Stock Forecast and Price Target 2026 $APRE - MarketBeat | Aprea Therapeutics (APRE) Stock Forecast and Price Target 2026 $APRE MarketBeat | View source ↗ | MarketBeat | May 11, 2024 | neutral | 0 | 0.6 |
| Aprea Therapeutics: APRE Stock Price Quote & News - Robinhood | Aprea Therapeutics: APRE Stock Price Quote & News Robinhood | View source ↗ | Robinhood | Jul 25, 2023 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for Aprea Therapeutics (APRE) - Zacks Investment Research | What is the current Price Target and Forecast for Aprea Therapeutics (APRE) Zacks Investment Research | View source ↗ | Zacks Investment Research | Aug 29, 2022 | neutral | 0 | 0.6 |
| Aprea Therapeutics Stock Price Forecast. Should You Buy APRE? - StockInvest.us | Aprea Therapeutics Stock Price Forecast. Should You Buy APRE? StockInvest.us | View source ↗ | StockInvest.us | Dec 4, 2020 | neutral | 0 | 0.6 |
| Aprea Therapeutics, Inc. (APRE) stock price, news, quote and history - Yahoo Finance UK | Aprea Therapeutics, Inc. (APRE) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Jun 13, 2017 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.